Manif Finance: The Funding Stack, The Covenants, And What Series D Really Said
A follow-up to the 2025 Manif analysis: the company’s funding mix is broader than the balance sheet alone suggests, but it is also more conditional. The bank lines, the Clal structure, the dividend restrictions, and Series D all show that flexibility exists, but it comes with a price and with real discipline.
The main 2025 article on Manif ended on a simple conclusion: growth is no longer the hard question. Funding quality is. This follow-up isolates that exact point. Not underwriting quality, not provisioning, but who funds Manif, on what terms, and how much of the company’s room to keep growing is real room rather than lines that still depend on outside approval.
That is where the picture gets more interesting than the usual headline about “another credit line” or “another bond issue.” Manif is not funded by a single layer. It has banks, non-recourse structures with financial institutions, a live bond market, and accounting and covenant mechanics that let it expand the book without every new shekel hitting the balance sheet in the same way. That is the real story.
But it is not a story of unconstrained flexibility. The board says there is no liquidity problem, and in the same breath frames that conclusion as dependent on maintaining bank lines and on the ability to raise additional funding from banks and the capital market. In other words, Manif’s liquidity is not self-contained. It is the liquidity of a lender that keeps growing as long as funding pipes stay open.
Five points are worth locking in at the start:
- The system is broader than the balance sheet. Alongside bank debt and bonds that sit on balance sheet, there is also the Clal non-recourse structure, which expands volume without loading the entire amount onto liabilities.
- Bond covenant headroom looks reasonably comfortable. Net equity to net balance sheet stood at about 19.7% versus a 17% distribution threshold and a 15% acceleration threshold, while equity was roughly NIS 690 million versus a NIS 350 million distribution threshold for Series D.
- The banking side is disciplined, but less transparent on true headroom. The company discloses the 15% equity tests, the 82% to 85% LTV caps, and dividend limits, but not the current live ratios against each bank.
- Series D was a valid deal, not a blank check. The book cleared at the maximum coupon of 5.37%, without underwriting, and below the full amount that was offered.
- The fixed coupon is only part of the economics. Manif swapped Series D into Bank of Israel rate plus 1.98%, so the true economic cost remains tied to rates.
The Funding Stack Is Not Just Banks, And Not Just Bonds
At the end of 2025, Manif’s funding mix included about NIS 1.953 billion from banks, about NIS 179.4 million from financial institutions recognized on balance sheet, and about NIS 813 million of bonds. That is already a broad liability structure, but it is still not the whole picture.
The part that really changes the read is the Clal structure. Under that arrangement, the total joint framework is NIS 500 million, of which Clal provides 60%, or up to NIS 300 million. By the reporting date, about NIS 235 million had already been received from Clal. That money is not shown in the balance sheet like ordinary debt because the company presents only its net share, and its agreements with other lenders require those balances to be deducted from covenant calculations as well.
That matters because Manif is not just raising more money. It is also building a layer that is easier on the balance sheet. Economically, it is a way to expand the book without making every unit of growth consume capital in the same way. From an accounting and covenant perspective, it creates room. It is not identical to full spread lending kept entirely on balance sheet: under the Clal structure, Manif earns a 2% excess return on the funds Clal provides. So this is not the same margin economics as core lending, but it is clearly a more capital-efficient way to add volume.
The maturity shift matters too. By year-end 2025, Manif had about NIS 1.263 billion of funding with a two to three year tenor, up from about NIS 1.031 billion a year earlier. At the same time, short-term loans fell to about NIS 866 million from about NIS 922 million. Put simply, the company did not just add channels. It pushed more of the structure outward in duration.
Liquidity Exists, But It Is Conditional
The board concluded that the company has no liquidity problem after reviewing a two-year cash flow forecast. That is important, but the wording around that conclusion is just as important. The conclusion explicitly rests on three conditions: ongoing normal operations, maintaining credit lines, and the ability to raise additional credit from banks and the capital market. This is not self-funded liquidity.
The year-end utilization profile reinforces that reading. Manif had drawn roughly NIS 1.865 billion of long-term facilities out of NIS 1.865 billion, which means the long-dated layer was essentially full. By contrast, it had drawn only about NIS 88 million of short-term facilities out of roughly NIS 615 million. That does create flexibility, but much of that flexibility sits in short-term facilities that renew annually, not in a permanently idle cash pile.
After the balance sheet date, two more pieces were added: the NIS 189.3 million Series D issue and an additional NIS 250 million line from Bank E. The late January immediate report already shows total bank lines of NIS 2.675 billion. On one level, that strengthens the case that Manif can keep widening its funding pipes. On another level, the new Bank E line did not come without discipline: at least 15% tangible equity to tangible balance sheet, no more than 83% LTV on pledged agreements, and a credit-loss ratio capped at 3%, with draws stopping already at 2.5%.
So Manif’s liquidity depends on the system remaining willing to fund it, but also on asset quality and capital staying strong enough to avoid tripping those brakes.
| Funding layer | What it opens up | What constrains it in practice |
|---|---|---|
| Banks | Large committed lines, lender diversification, a good match for prime-linked lending | Pledged financing agreements, cross-default clauses, capital and LTV tests, and in Bank E’s case a direct credit-loss trigger |
| Clal | More balance-sheet-efficient growth, with 60% non-recourse funding on eligible deals | Eligibility criteria, a 2% excess return rather than the full spread, and continued partner willingness to provide capital |
| Bonds | Longer duration and access beyond the banking system | The series are unsecured, so pricing and covenants are the market’s main protection |
| Dividends | Lets management keep signaling confidence and return capital | Constrained by lenders and bondholders, not just by accounting surplus |
Covenants: There Is Room, But Not Freedom
On the bond side, the picture is actually fairly comfortable. Across the series, including Series D, net equity to net balance sheet stood at about 19.7% at the end of 2025. The distribution threshold is 17%, the coupon step-up threshold is 16%, and the acceleration threshold is 15%. On the absolute equity side, the company is not close to the edge either: about NIS 690 million of equity versus a NIS 350 million distribution threshold for Series D, NIS 325 million for a step-up, and NIS 310 million for acceleration.
The important point is not just that there is room. It is where that room is actually disclosed. In the bond layer, readers get a relatively full picture: the actual ratio, the distribution threshold, the step-up threshold, and the acceleration threshold. In the banking layer, Manif mostly gives the covenant framework and confirms compliance. That is enough to show there is no immediate pressure, but not enough for outsiders to measure true headroom with the same precision. There is no disclosed live LTV against each bank, and no disclosed current bank-by-bank covenant distance that would let investors rebuild the cushion themselves.
That is why the broad statement that “Manif is not close to covenants” is only partly precise. On the bond side, it looks fully correct. On the banking side, the company says it is compliant, but it does not give investors the whole ratio set needed to quantify the distance independently. What is clear, however, is that dividend restrictions are spread across almost the entire system: Bank B requires approval if equity to balance sheet falls below 20%, Bank D allows dividends only out of current profits, the Bank C plus financial institutions group caps distributions at 65% of net income and only absent a breach event, and the bond deeds impose the same 65% ceiling.
In practice, that means surplus alone does not determine what Manif can distribute. Its funders do.
What Series D Really Said
This is probably the sharpest signal in the whole funding story. Midroog assigned an A3.il issuer and series rating with a stable outlook, and in the January update it approved up to NIS 226 million par for Series D instead of the NIS 150 million that had been rated before. On the surface, that looks reassuring. In reality, the book itself sent the more informative message.
The public offer was for up to NIS 225.966 million par. Early commitments from classified investors amounted to NIS 183.369 million par, or 81.15% of the offered size. In the end, accepted orders came to NIS 189.304 million par, and the coupon was set exactly at the ceiling, 5.37%. The deal was not underwritten.
The easiest number to miss is not only that the issue did not clear in full, but how little incremental demand there was beyond the early anchor book. The gap between NIS 183.369 million of early commitments and NIS 189.304 million ultimately accepted is just NIS 5.935 million. In other words, almost the entire order book was effectively pre-built, and the wider market added very little beyond it.
That matters. This was not a failed deal, but it was not a clean vote of confidence either. The market told Manif yes, but at the maximum coupon, without underwriting, and without absorbing the full amount on offer. That is exactly what disciplined market access looks like.
There is another layer here. The 5.37% coupon is an important headline, but it is not the full economic cost. A day after the issue was completed, Manif swapped the fixed rate into a structure where it receives 5.37% fixed and pays Bank of Israel rate plus 1.98%. So even the most capital-markets-looking part of the stack still ends up behaving like variable-rate bank funding.
Rates, Dividends, And What Will Drive The Next Read
Manif itself says that about 99.8% of its customer credit book carries variable interest, while about 78% of the funding sources behind that book are variable as well. That means rate increases lift revenue more than they lift funding cost, while rate cuts do the reverse. So anyone reading Series D as a simple fixed-rate lock is missing the core point. Manif’s economics remain tightly linked to the rate backdrop.
That also matters for dividends. The company’s stated policy is to distribute 50% of annual net profit, but at year-end 2025 it had about NIS 462.64 million of retained earnings available in principle and only about NIS 202.21 million that could actually be distributed under funding-document constraints. It paid NIS 61 million in dividends during 2025, and after the balance sheet date another NIS 36 million dividend was approved.
That creates a two-sided read. On one side, management is signaling that it sees enough room to keep paying out. On the other side, the funding structure is not being built solely for growth. It also has to support distributions. As long as equity keeps growing fast enough to satisfy lenders, that balance can hold. If loan book growth starts to outrun equity, or if credit quality begins to erode covenant cushions, dividends are likely to be one of the first places where pressure shows up.
Bottom Line
This follow-up leads to a sharper version of the “funding quality” thesis. Manif now has a broader, more layered, and more sophisticated funding system: banks, bonds, non-recourse institutional money, and rate hedges that pull the whole structure back into one economic logic. In that sense, the company has built a real platform for continued growth.
But that platform is not automatic. It lives on the confidence of banks, bondholders, and institutional partners. Series D showed that access is there, but at a disciplined price. Bond covenant room currently looks comfortable, yet dividends, the rating, capital ratios, and credit losses are already tied directly to the ability to keep those funding pipes open.
For Manif, then, the funding stack is not just a balance-sheet line item. It is the company’s second product. And the market has already started pricing that product with far less generosity than it prices raw growth.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.